(Q40716583)

English

Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients

scientific article published on August 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Franck Housseau

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Kimberly R Lindsey

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Samuel D Oberholtzer

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Monica I Gonzales

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Paula Boutin

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Anitha K Moorthy

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Srinivas Shankara

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Bruce L Roberts

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Suzanne L Topalian

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Journal of Immunological Methods

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

266

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

87-103

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Recombinant viruses as a tool for therapeutic vaccination against human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Analysis of cellular immune responses in the peripheral blood of mice using real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Status of activation of circulating vaccine-elicited CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Overview of melanoma vaccines: active specific immunotherapy for melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

A listing of human tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

The promise of nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Progress in human tumour immunology and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Identification of endogenous HLA-A2-restricted reactivity against shared melanoma antigens in patients using the quantitative real-time polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Human tumor antigens for cancer vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

T-cell-directed cancer vaccines: the melanoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900104-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-1759(02)00104-7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40716583&oldid=2144033961"